Endocrine Testing Market Size & Forecast Report - 2026 to 2030

The global endocrine testing market size is projected to grow at a significant CAGR of over 8% during the forecast period from 2022 to 2028. The rising prevalence of endocrine disorders and the growing awareness regarding early detection and treatment are some major factors driving the market growth. Furthermore, the rising prevalence of diabetes and thyroid disease, the growing rate of obesity, and the growth in the geriatric population around the globe are some major factors driving the market growth. According to the WHO (World Health Organization), in 2022, it is estimated that more than 1 billion people are obese across the world, 650 million adults, 340 million adolescents, and 39 million children.  Moreover, the increasing investment in research & development and the growing technological development are anticipated to fuel the market over the forecast period.

Market Drivers:

Increasing Prevalence of Endocrine Disorders: The rising prevalence of endocrine disorders, such as diabetes, thyroid disorders, and hormonal imbalances, is a significant driving factor for the endocrine testing market. As the incidence of these disorders continues to increase globally, there is a growing need for accurate diagnosis, monitoring, and management of endocrine conditions, driving the demand for endocrine testing.

Growing Aging Population: The aging population is more susceptible to endocrine disorders, as hormonal imbalances and dysfunctions become more common with age. As the global population ages, the demand for endocrine testing is expected to rise. Early detection and management of endocrine disorders in the elderly population are crucial for maintaining their health and well-being.

Advancements in Testing Technologies: Advances in diagnostic technologies have improved the accuracy, efficiency, and accessibility of endocrine testing. The development of automated immunoassays, molecular diagnostics, and point-of-care testing devices has expanded the capabilities of endocrine testing, allowing for faster and more precise results. Technological advancements drive market growth by enhancing the quality and convenience of endocrine testing procedures.

Increasing Awareness and Screening Programs: Growing awareness about endocrine disorders and the importance of early detection has led to the implementation of screening programs and initiatives by healthcare organizations and governments. These programs aim to identify individuals at risk or in the early stages of endocrine disorders. The expansion of screening programs contributes to the demand for endocrine testing services and products.

Emphasis on Personalized Medicine: The concept of personalized medicine, which involves tailoring medical treatments and interventions based on individual patient characteristics, is gaining prominence. Endocrine testing plays a crucial role in identifying specific hormonal imbalances and guiding personalized treatment plans. The increasing focus on personalized medicine drives the demand for endocrine testing to support individualized patient care.

Growing Healthcare Expenditure: Increasing healthcare expenditure across the globe is a driving factor for the endocrine testing market. Healthcare systems are allocating more resources to diagnostic services, including endocrine testing, to improve patient outcomes and reduce long-term healthcare costs. The availability of healthcare funding and reimbursement policies influences the demand for endocrine testing services.

Research and Development Activities: Ongoing research and development activities in the field of endocrine testing contribute to market growth. Researchers are continuously working on the development of novel biomarkers, testing methods, and diagnostic technologies to enhance the accuracy and efficiency of endocrine testing. The advancement of research initiatives expands the possibilities and applications of endocrine testing, driving market growth.

Market Snapshot:

Market Insights:

By tet type, the hCG test segment dominated the global market in 2021

The global endocrine testing market is bifurcated into test type, technology, end-user, and geography. On the basis of test type, the market is further segmented into hCG test, thyroid test, FSH test, insulin test, and others. The hCG test is accounted to hold the largest revenue share in 2021. The high number of self-test pregnancy kits and the need for quantitative estimation of hCG in hospitals or laboratories are some significant factors to drive the segment growth. furthermore, the determination of hCG levels to detect abnormalities during different stages of pregnancy, as well as increasing number of fertile female population are further anticipated to fuel the segment growth. On the flip side, the insulin test segment is accounted to register the fastest growth over the forecast period.

By technology, the immunoassay segment is expected to hold the largest revenue share by 2028

On the basis of technology, the market is segmented into mass spectroscopy, immunoassay, chromatography, and nucleic acid based. The immunoassay technology segment dominated the global endocrine testing market in 2021 and estimated to hold a significant revenue share of over 1/3 of the market. The widespread use of the technology for diagnosis and quantitation of endocrine hormones are some major factor to drive the segment growth. Furthermore, the availability of several instruments and analyzers that use a variety of immunoassay techniques for detection is further anticipated to propel the segment growth.

To know more about the report, request sample papers

The endocrine testing comprehensive study analyzes industry trends, market size, competitive analysis, and market forecast – 2022 to 2028. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The endocrine testing market research report presents the analysis of each segment from 2019 to 2028 considering 2021 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2022 to 2028.

Historical & Forecast Period

• 2019-20 – Historical Year
• 2021 – Base Year
• 2022-2028 – Forecast Period

Market Segmentation:

By Test Type:

• Follicle Stimulating Hormone (FSH) Test
• Human Chorionic Gonadotropin (hCG) Hormone Test
• Luteinizing Hormone (LH) Test
• Dehydroepiandrosterone Sulfate (DHEAS) Test
• Progesterone Test
• Thyroid Stimulating Hormone (TSH) Test
• Prolactin Test
• Insulin Test
• Others

By Technology:

• Mass Spectroscopy
• Immunoassay
• Chromatography
• Nucleic Acid Based

By End-User:

• Hospitals
• Commercial Laboratories
• Ambulatory Care Centers
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis:

By region, North America is accounted to hold the largest revenue share in 2021

On the basis of region, North America dominated the global endocrine testing market in 2021 and is anticipated to grow at the same trend over the forecast period. The higher prevalence of diabetes and the growth in the obese population are some major factors to drive the market growth in the region. Furthermore, the significant availability of reimbursement centers and the growing investment by the government for better healthcare facilities are further anticipated to fuel the market growth in North America. Moreover, the growing geriatric population, rising awareness, and the presence of some major market players are projected to propel the market growth.

Geographically, the endocrine testing market report comprises dedicated sections centering on the regional market revenue and trends. The endocrine testing market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The endocrine testing market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. Endocrine testing market estimates have also been provided for the historical years 2019 & 2020 along with forecasts for the period from 2022 – 2028.

Competitive Assessment:

Some of the major market players operating in the global endocrine testing market are Abbott Laboratories, AB Sciex, Agilent Technologies Inc., bioMerieux SA, and Bio-Rad Laboratories Inc. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

• Abbott Laboratories
• AB Sciex
• Agilent Technologies Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• DiaSorin S.p.A.
• Hoffmann-La Roche Ltd.
• Laboratory Corporation of America Holdings
• Quest Diagnostics Incorporated
• Ortho Clinical Diagnostics

Key Questions Answered by Endocrine Testing Market Report

• Global endocrine testing market forecasts from 2022-2028
• Regional market forecasts from 2022-2028 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
• Country-level forecasts from 2022-2028 covering 15 major countries from the regions as mentioned above
• Endocrine testing submarket forecasts from 2022-2028 covering the market by test type, technology, end-user, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis about the market
• Analysis of the key factors driving and restraining the growth of the global, regional, and country-level endocrine testing markets from 2022-2028
• Competitive Landscape and market positioning of top 10 players operating in the market